FREMONT, Calif. — Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced the addition of two industry leaders focused on driving operational excellence and commercial adoption. The appointments follow the strong uptake of Ultima’s technology in clinical applications and will accelerate the Company’s path towards expanded clinical utilization as well […]
BiotageAB (STO:BIOT) (“Biotage”), the leading global separations Company developing intelligent workflow solutions for drug discovery and development through to diagnostics, has today announced the appointment of Frederic Vanderhaegen as Chief Executive Officer, effective September 16th 2024. Mr. Vanderhaegen succeeds Torben Jørgensen, who stepped in as interim CEO in January 2024 and he will now continue […]
LEBANON, N.H. — Bio X Cell, LLC (“BXC” or the “Company”), a leading producer of monoclonal antibodies for pre-clinical in vivo research applications, is pleased to announce the appointment of Christopher Conway as Chief Executive Officer. Bio X Cell is a leading producer of monoclonal antibodies (mAbs) primarily for use in preclinical in vivo research […]
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michael Feld has been named executive vice president and president of the Life Sciences segment for BD, effective Aug. 20, 2024, and will serve as a member of the Executive Leadership Team. He succeeds Dave Hickey, who retired from BD […]
TAIPEI, Taiwan & WATERTOWN, Mass. — Syncell, a leader in next-generation spatial proteomics, is pleased to announce the addition of Philippe C. Lyko as Chief Financial Officer (CFO) and Nikhil Rao, PhD, as Senior Vice President of Commercial. These appointments strengthen Syncell’s leadership team as the company enters a pivotal phase of growth and commercial […]
Berwyn, Pa. – AMETEK, Inc. (NYSE: AME) today announced the appointment of John C. Henriques as Vice President, Corporate Development. “I am very pleased to announce John’s promotion to this important role, as he has been a valuable contributor to our Corporate Development team,” commented David A. Zapico, AMETEK Chairman and Chief Executive Officer. “His […]
Berwyn, Pa. – AMETEK, Inc. (NYSE: AME) today announced the appointment of Rob Rideout Jr. as Vice President, Strategic Procurement. “I am delighted to promote Rob to Vice President, Strategic Procurement,” said David A. Zapico, AMETEK Chairman and Chief Executive Officer. “Rob’s exceptional leadership and expertise in supply chain management have been invaluable. We are […]
PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today several changes to its executive team. Mennah Moustafa has been named Chief Commercial Officer, effective August 1. In this role, Moustafa will be responsible for driving commercial strategy and execution and leading the company’s sales, support and marketing functions. Justin McAnear, […]
Mr. Field Bian has been appointed as the new Group CEO of TECHCOMP Instrument Limited, effective August 1, 2024. Mr. Bian will be responsible for managing all TECHCOMP companies globally, including subsidiaries in Europe such as Edinburgh Instruments, Scion Instruments, Precisa, Froilabo, Isotopx, and all Techcomp operations in Americans and Asia. Mr. Bian previously held […]
Cambridge, UK – bit.bio, the company coding human cells for novel cures and a pioneer in the field of synthetic biology, today announces the appointment of Przemek Obloj as Chief Financial Officer. Mr. Obloj will oversee the company’s financial strategy, including fundraising, and work closely with Founder and CEO, Mark Kotter, and the Executive Team […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
